These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34239695)

  • 21. Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditions.
    Schöndorf T; Karagiannis E; Posseldt RE; Forst T; Pfützner A
    Diabetes Technol Ther; 2009 Jun; 11(6):379-83. PubMed ID: 19459767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin.
    Kashi Z; Mahrooz A; Kianmehr A; Alizadeh A
    PLoS One; 2016; 11(3):e0151543. PubMed ID: 26978661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
    Dailey GE; Mohideen P; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypovitaminosis D in type 2 diabetes: relation with features of the metabolic syndrome and glycemic control.
    Miñambres I; Sánchez-Quesada JL; Vinagre I; Sánchez-Hernández J; Urgell E; de Leiva A; Pérez A
    Endocr Res; 2015; 40(3):160-5. PubMed ID: 25536005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Vitamin D on glycemic control and oxidative stress in type 2 diabetes mellitus.
    Saif-Elnasr M; Ibrahim IM; Alkady MM
    J Res Med Sci; 2017; 22():22. PubMed ID: 28413419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D Deficiency May Not Be an Independent Risk Factor for Peripheral Arterial Disease in Middle-Aged and Elderly Patients with Type 2 Diabetes in China.
    Wang Y; Feng T; Zhou H; Lu K; Bai Y; Zhang P
    Dis Markers; 2020; 2020():8854717. PubMed ID: 33299499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.
    Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF
    J Clin Pharm Ther; 2009 Feb; 34(1):13-23. PubMed ID: 19125899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term antidiabetic treatment with insulin or metformin has a similar impact on the components of metabolic syndrome in women with gestational diabetes mellitus requiring antidiabetic agents: results of a prospective, randomised study.
    Zawiejska A; Wender-Ozegowska E; Grewling-Szmit K; Brazert M; Brazert J
    J Physiol Pharmacol; 2016 Apr; 67(2):227-33. PubMed ID: 27226182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypovitaminosis D in patients with type 2 diabetes: risk factors and association with glycemic control and established microvascular complications.
    Ramírez Stieben LA; Dobry R; Anca L; González A; López MI; Bayo S; Sánchez A; Brance ML
    Rev Fac Cien Med Univ Nac Cordoba; 2022 Sep; 79(3):235-240. PubMed ID: 36149074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between 25 Hydroxyvitamin D, Overweight/Obesity Status, Pro-Inflammatory and Oxidative Stress Markers in Patients with Type 2 Diabetes: A Simplified Empirical Path Model.
    Cătoi AF; Iancu M; Pârvu AE; Cecan AD; Bidian C; Chera EI; Pop ID; Macri AM
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Prevalence of Hypovitaminosis D in Postmenopausal Women with Type 2 Diabetes Mellitus.
    Raška I; Rašková M; Zikán V; Škrha J
    Prague Med Rep; 2016; 117(1):5-17. PubMed ID: 26995199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
    Yale JF; Valiquett TR; Ghazzi MN; Owens-Grillo JK; Whitcomb RW; Foyt HL
    Ann Intern Med; 2001 May; 134(9 Pt 1):737-45. PubMed ID: 11329231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D3 deficiency is associated with more severe insulin resistance and metformin use in patients with type 2 diabetes.
    Aludwan M; Kobyliak N; Abenavoli L; Kyriienko D; Fagoonee S; Pellicano R; Komisarenko I
    Minerva Endocrinol; 2020 Sep; 45(3):172-180. PubMed ID: 33000618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D Status in Newly Diagnosed Type 2 Diabetes Patients Attending in a Tertiary Hospital of Bangladesh.
    Alam MS; Kamrul-Hasan M; Kalam ST; Selim S; Akter F; Saifuddin M
    Mymensingh Med J; 2018 Apr; 27(2):362-368. PubMed ID: 29769503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D status and its association with antioxidant profiles in diabetic patients: A cross-sectional study in Iran.
    Saedisomeolia A; Taheri E; Djalali M; Djazayeri A; Qorbani M; Rajab A; Larijani B
    Indian J Med Sci; 2013; 67(1-2):29-37. PubMed ID: 24178339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
    Derosa G; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Montagna L; Gravina A; Ferrari I; Paniga S; Cicero AF
    J Clin Pharm Ther; 2006 Aug; 31(4):375-83. PubMed ID: 16882108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.